Joshua Barocas, Mahesh Bhatt, Emily Blumberg, Cody Chastain, Greg Corby-Lee, Laura Fanucchi, Jason Halperin, Nicole Leedy, Jeffrey Lennox, Ginat Mirowski, Melissa Osborn Jenkins, Anna Person, Meenakshi Rana, Christine Teague, Alice Thornton, Phyllis Tien, David Wyles

Joshua Barocas, MD

Assistant Professor, Medicine, Infectious Diseases
Boston University School of Medicine
Infectious Disease Clinician
Boston Medical Center
Boston, Massachusetts

Dr. Barocas earned an MD from the George Washington University School of Medicine and Public Health. He completed residency and chief residency in Internal Medicine at the University of Wisconsin Hospitals and Clinics. Dr. Barocas completed a fellowship in infectious diseases at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, Massachusetts.

He is an infectious diseases physician with an expertise in the infectious complications of drug use. His research focus is in clinical decision-making and health policy at the intersection of substance use and infectious diseases.

Dr. Barocas has worked on issues related to the infectious and non-infectious complications of substance use. Recent and ongoing projects include estimation of the prevalence of opioid use disorder in Massachusetts, social determinants of non-opioid overdose death, and mathematical modeling to evaluate the clinical impact, costs, and cost effectiveness of integrated substance use treatment and HCV treatment among HIV-infected persons. He is developing a simulation model of injection opioid use-related bacterial infections to estimate the long-term impact and cost-effectiveness of hospital-based interventions that are designed to improve outcomes in this population.

Back to top

Mahesh Bhatt, MD

Fellow, Internal Medicine, Infectious Diseases
University of Kentucky College of Medicine
Lexington, Kentucky

Dr. Bhatt earned a medical degree from the College of Medical Sciences in Nepal. He worked for two years in rural and underprivileged areas of the country caring for HIV and TB patients. He then completed an Internal Medicine residency at the Jersey City Medical Center (JCMC) in Jersey City, New Jersey. Dr. Bhatt served on the teaching faculty of the JCMC residency program as a hospitalist for three years.

Clinical interests include HIV, tuberculosis, and fungal infections.

Back to top

Emily Blumberg, MD

Professor, Medicine, Infectious Diseases
Director, Transplant Infectious Diseases
Program Director, Infectious Diseases Fellowship
Perelman School of Medicine of the University of Pennsylvania
Philadelphia, Pennsylvania

Dr. Blumberg earned an MD from New York University, completed residency at University of Chicago Medical Center, and a fellowship at Albert Einstein - Montefiore Medical Center.

Dr. Blumberg's research focuses on donor derived infections and viral infections in transplant recipients including HIV and HCV. She has also been involved in clinical trials related to new antimicrobial agents, especially antivirals. She is a former chair of the OPTN/UNOS Ad Hoc Disease Transmission Advisory Committee and has been extensively involved in the development of guidelines for the prevention of donor derived infections.

She is an Associate Editor for the American Journal of Transplantation and Transplant Infectious Diseases, President-Elect of the American Society for Transplantation, co-chair of the US Health and Human Services Advisory Committee on Blood and Tissue Safety and Availability, and Chair of the IDSA Training Program Directors Committee.

Back to top

Cody Chastain, MD

Assistant Professor, Medicine
Viral Hepatitis Program, Infectious Diseases
Vanderbilt University Medical Center
Nashville, Tennessee

Dr. Chastain graduated from Loma Linda University School of Medicine in Loma Linda, California, and was awarded the Chancellor's Award as the top overall graduate. He completed his training in Internal Medicine at Duke University Medical Center in Durham, North Carolina, where he was awarded the Haskel Schiff Award for excellence in the practice of clinical medicine. After working as a hospitalist for Duke University Health Systems, Dr. Chastain trained as a clinical fellow in the Division of Infectious Diseases at Vanderbilt University Medical Center. He currently leads the division's Viral Hepatitis Program. He is an active educator at the Vanderbilt University School of Medicine and serves as the Viral Hepatitis Project Director for the Southeast AIDS Education and Training Center.

He has an active interest in Hepatitis C Virus (HCV) infection as well as HIV. He also has an interest in clinical research, innovative public health strategies, and medical education.

Dr. Chastain has been honored as an Outstanding Fellow at Vanderbilt University.

Back to top

Greg Corby-Lee

Harm Reduction Strategist
University of Kentucky and Kentucky Department for Public Health
Lexington, Kentucky

Greg studied both Computer Science and Health Administration at the University of Kentucky.

He served as the AIDS Coordinator (and a Disease Intervention Specialist for HIV) at the Lexington-Fayette County Health Department (LFCHD) for six years and then was promoted to HIV/STD Manager at LFCHD for 15 years. Before attempting retirement after 32 years in Public Health and HIV, Greg was the KDPH HIV Continuing Education Director for eleven years. While at KDPH, Greg served his last few years as the “point person” for Kentucky’s Harm Reduction/Syringe Exchange Program (HRSEP) efforts and facilitated enormous growth of HRSEPs across Kentucky (three were established before he was this HRSEP point person for KDPH, and 43 were established when he retired).

Back to top

Laura Fanucchi, MD, MPH

Assistant Professor, Medicine, Infectious Disease
University of Kentucky College of Medicine and the Center on Drug and Alcohol Research
UK Addiction Consult and Education Service
Lexington, Kentucky

Dr. Fanucchi earned an MD and MPH from Emory University, and completed an Internal Medicine residency and Chief Residency at New York-Presbyterian Hospital/Weill Cornell. She is board-certified in Internal Medicine and Addiction Medicine.

She provides treatment for opioid use disorder in the UK Bluegrass Care Clinic and in the UK First Bridge Clinic.

Dr. Fanucchi's research focus is in integrating evidence-based treatment of opioid use disorder in medically complex patient populations. She has presented regionally and nationally on the management of hospitalized patients with opioid use disorder, and provides trainings to physicians and other members of the healthcare team.

Back to top

Jason Halperin, MD, MPH

Crescent Care
Assistant Professor, Medicine
Tulane University’s School of Medicine
New Orleans, Louisiana

Dr. Halperin earned an MPH from Columbia University in New York followed by and MD from the University of Vermont College of Medicine in Burlington, Vermont. He completed residency at the Tulane University Department of Internal Medicine in New Orleans. Following residency, Dr. Halperin completed an infectious diseases fellowship at New York University.

His areas of interest are HIV, Hepatitis C, and HIV prevention services such as PrEP.

Dr. Halperin strongly believes in the importance of clinical research and quality innovations. He is the principal investigator of two on-going clinical trials and oversees HIV quality work at CrescentCare including its nationally recognized Rapid Start program.

Dr. Halperin is also a member of the New Orleans Regional AIDS Planning Council.

Back to top

Nicole Leedy, MD

Assistant Professor, Medicine, Internal Medicine
Associate Infectious Diseases Fellowship Program Director
University of Kentucky College of Medicine
Lexington, Kentucky

Dr. Leedy completed her medical training at the Loan C. Edwards School of Medicine at Marshall University in Huntington, West Virginia. She completed a combined residency in Internal Medicine and Pediatrics and a fellowship in Infectious Diseases at the University of Kentucky.

She is certified by the American Board of Internal Medicine and the American Board of Pediatrics.

She currently is an investigator/co-investigator for her institution’s Ryan White Program, a member of the GERM Medical Student Program Committee for the IDSA/HIVMA, as well as a lecturer for the KY AIDS Education and Training Center.

Her clinical interests include HIV and STDs with a special interest in adolescent populations.

She was named to the Best Doctors in America in 2018.

Back to top

Jeffrey Lennox, MD, FIDSA

Professor, Medicine
Associate Dean, Clinical Research
Co-Principal Investigator, Emory-CDC HIV Clinical Trials Unit
Co-Director, Emory CFAR Clinical Research Core
Vice Chair, Grady Affairs, Medicine
Emory University School of Medicine
Atlanta, Georgia

Dr. Lennox earned an MD from the University of Colorado in Boulder. He completed his residency and fellowship in internal medicine and infectious diseases at Walter Reed Army Medical Center in Bethesda, Maryland.

He is certified by the American Board of Internal Medicine and the Subspecialty Board for Infectious Disease.

Dr. Lennox served in the United States Army Medical Corps and achieved the rank of Major.

Dr. Lennox’s most widely cited publications are in the fields of Antiretroviral Therapy, Infectious Complications of HIV and Genital Shedding of HIV.

Dr. Lennox currently serves on the Department of Health and Human Services Adult/Adolescent Antiretroviral Guidelines Panel. He has served on several committees within the AIDS Clinical Trials Group, has served as an advisor for the Division of AIDS at NIAID, and for other governmental entities.

In 2008, he was awarded the Clinician Educator of the Year Award from the HIV Medicine Association.

Back to top

Ginat Mirowski, DMD, MD

Associate Professor, Dermatology
Indiana University School of Medicine
Attending Physician
Clarian Health-Methodist/IU/Riley Hospitals
Consulting Attending
Richard L. Roudebush VAMC
Indianapolis, Indiana

Dr. Mirowski earned an MD from the Harvard Medical School in Boston, Massachusetts, and a DMD from Harvard School of Dental Medicine. She completed a residency in Oral Medicine at HSDM, a medicine internship at U of Massachusetts in Worcester, Massachusetts, and a residency in Dermatology at the University of California San Francisco.

Dr. Mirowski is certified by the American Board of Dermatology.

She currently specializes in Mucosal Dermatology and sees patients in the Dermatology Department (out-patient center in Indianapolis). She is the author of 40 peer reviewed articles and 53 chapters.

Back to top

Melissa Osborn Jenkins, MD, MS

Associate Professor, Medicine
Case Western Reserve University School of Medicine
Staff Physician, Infectious Diseases
MetroHealth Medical Center
Cleveland, Ohio

Dr. Jenkins earned a BS from Mount Union College, an MD from The Ohio State University, and an MS in Clinical Research from Emory University. She completed residency and an ID fellowship at Emory University School of Medicine in Atlanta. She spent part of her fellowship doing special training in viral hepatitis, which is her area of clinical and research interest. She is board-certified in Internal Medicine and Infectious Diseases.

Dr. Jenkins has thirteen years of post-training experience in the care of HIV and hepatitis C patients, as well as those with general infectious diseases. Her clinical practice is at MetroHealth Medical Center, Cleveland’s public hospital, where she is also the Internal Medicine Clerkship Director for third-year medical students.

In addition to clinical practice, she is involved in several collaborative research projects evaluating new models of care: hepatitis C screening in inpatient and ED settings and provision of buprenorphine therapy in the HIV clinic.

Back to top

Anna Person, MD

Program Director, ID Fellowship Program
Clinical Director, SE AIDS Education and Training Center
Associate Professor, Medicine, Infectious Diseases
Vanderbilt Comprehensive Care Clinic
Nashville, Tennessee

Dr. Person earned an MD from George Washington University. She complete an Internal Medicine residency and an Infectious Diseases fellowship at the Duke University Medical Center.

She works primarily at the Vanderbilt Comprehensive Care Clinic, providing primary care and HIV specialty care to HIV-infected individuals.

Research areas of interest include determining best practices for providing cultural competent, supportive health care for transgender individuals while promoting empowerment and well-being.

Back to top

Meenakshi Rana, MD

Assistant Professor, Medicine, Infectious Disease
Director, Transplant Infectious Diseases
Icahn School of Medicine at Mount Sinai
New York, New York

Dr. Rana earned an MD from Brown University. She completed internal medicine residency at University of Michigan followed by infectious disease fellowship at Mount Sinai Hospital.

She subsequently joined as transplant infectious disease faculty at Mount Sinai and is now is now director of the transplant infectious diseases program.

Back to top

Christine Teague, PharmD, MPH, AAHIVP

Infectious Diseases Clinical Pharmacy Specialist
Ryan White Part C Program Director
Charleston Area Medical Center
Charleston, West Virginia

For the last twenty-four years, Dr. Teague has served as a clinical pharmacist specialist in Infectious Diseases with a focus on HIV/HCV at Charleston Area Medical Center (CAMC) in Charleston, West Virginia. Since 2001, Dr. Teague has served as program director of CAMC’s Ryan White Part C Early HIV Intervention Services Program. She began providing mobile harm reduction clinics to address substance use disorder in remote southern WV counties in collaboration with WV Health Right in the fall of 2017.

She holds adjunct clinical pharmacy faculty positions with both the West Virginia University School of Pharmacy and University of Charleston School of Pharmacy. Dr. Teague earned a BS in Pharmacy from the University of North Carolina at Chapel Hill and a PharmD from the Medical College of Virginia/Virginia Commonwealth University. She completed residency in Infectious Diseases Pharmacotherapy at the University of Rhode Island and later earned am MPH from West Virginia University.

Dr. Teague is a Board Certified Specialist in HIV from the American Academy of HIV Medicine (AAHIVM), on the AAHIVM MidAtlantic Steering Committee, and a member of the WVU School of Public Health Gamma Mu chapter of Delta Omega, the national Public Health Honorary Society. Dr. Teague is a member of the Society of Infectious Diseases Pharmacists (SIDP), the Infectious Diseases Society of America (IDSA) and the HIV Medicine Association (HIVMA). She is a current board member of West Virginia Health Right, Inc., the Living AIDS Memorial Garden, and Vestry member at St. John’s Episcopal Church.

Dr. Teague has given numerous invited lectures on HIV, Chronic Hepatitis C, and infectious diseases around the state and region and she has written grants for HIV and harm reduction work at CAMC totaling nearly $9 million.

Back to top

Alice Thornton, MD

Professor, Medicine
University of Kentucky College of Medicine
Chief, Infectious Disease
Project Director, Ryan White Part B, C, and D
Chair, KY AETC
UK HealthCare
Medical Director, Blue Grass Care Clinic
Lexington, Kentucky

Dr. Thornton earned an MD at Marshall University in Huntington, West Virginia. She completed residency at Wake Forest University School of Medicine in Internal Medicine. She then completed fellowship training with the Division of Infectious Disease at Indiana University Purdue University (IUPUI) where she studied the pathogenesis of chancroid. She was recruited to assist in the development of an Infectious Diseases Fellowship Program at the University of Kentucky in 1998.

While at UK, Dr. Thornton has successfully acquired four HRSA funded grants – Ryan White Part B, C and D and the Local Performance Site grant of the Southeast AIDS Training and Education Center. She is PI of a sub site for the NIH-funded Reprieve Study – Randomized Clinical Trial to Prevent Vascular Events in HIV.

Dr. Thornton is a clinical site visitor for HRSA and also serves as a grant reviewer on for the Health Resources and Services Administration (HRSA), National Institutes of Health (NIH), and the Centers for Disease Control and Prevention (CDC).

She has been the Infectious Diseases Research Professor in Internal Medicine since 2003 and has been named to the Best Doctors in America - Infectious Diseases, consecutively since 2005.

Back to top

Phyllis Tien, MD, MSc

Professor, Medicine, Infectious Diseases
University of California, San Francisco
Staff Physician
San Francisco Veterans Affairs Medical Center
San Francisco, California

Dr. Tien is engaged in clinical translational research of chronic viral infections, specifically HIV and HCV, and their metabolic and inflammatory consequences on long term organ injury (e.g. liver, bone and vascular injury). As part of this work, she also studies novel non-invasive techniques to estimate steatosis and fibrosis using magnetic resonance (MR) imaging and ultrasound-based transient elastography as well as novel CT and MR imaging methods to measure bone and vascular injury. She is the Principal Investigator of an NIH funded R01 study to investigate the link between visceral adiposity, HIV, and HCV to the pathogenesis of hepatic steatosis and fibrosis and an NIH funded K24 award to mentor early career investigators to examine the effects of HIV/HCV coinfection on liver, bone and vascular injury. She is also one of three Principal Investigators of the Northern California site of the Women's Interagency HIV Study (WIHS), which is the largest and longest running prospective cohort of the progression of HIV infection in women in the US.

She serves as the Chair of the WIHS Executive Committee, Chair of the NIH AIDS Clinical Epidemiology Study Section, and is a member of the Department of Health and Human Services Antiretroviral Therapy Guidelines Panel for Adults and Adolescents and the national VA HCV treatment recommendations panel.

Dr. Tien earned an MD from UC San Diego and an MSc from Harvard School of Public Health. She completed an Internal Medicine Residency and a fellowship in Infectious Diseases and Geographic Medicine at Stanford University.

Back to top

David Wyles, MD

Professor, Medicine, Infectious Diseases
University of Colorado Medical School
Aurora, Colorado
Chief, Infectious Diseases
Denver Health Medical Center
Denver, Colorado

A native of Ohio, Dr. Wyles attended Northwestern University for undergraduate studies and medical school, and completed his internal medicine residency and ID fellowship at the University of Colorado.

Since then, he has been at the University of California at San Diego, where he is Associate Professor of Medicine, Director of the UCSD Infectious Diseases HCV clinic, and Director of the Microbiology course for the UCSD School of Medicine.

Dr. Wyles has achieved an international reputation in the management of hepatitis C infection having done research both as a basic scientist and investigator in several important clinical trials, leading to major advances in this discipline.

Dr. Wyles’ research interests include the conduct of HCV clinical trials, HCV drug resistance, and the treatment of HCV in underserved populations.

He was an inaugural member of the AASLD/IDSA HCV guidelines panel and currently serves as Co-Chair on the panel. He is also a member of the International Antiviral Society–USA Hepatitis Advisory Board and the ACTG Hepatitis transformative science group. Clinically Dr. Wyles is involved in care of patients with HCV and HCV/HIV-1 co-infection.

Back to top